Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on March 20, 2025
Titan Machinery Inc. Announces Results for Fiscal Fourth Quarter and Full Year Ended January 31, 2025
GlobeNewswire
·
March 20, 2025
- Achieved Approximately $304 Million of Inventory Reduction in the Fiscal Fourth Quarter, Bringing Total Inventory Reduction Since Fiscal Second Quarter Peak to $419 Million - - Service Revenue Increased 14.5% , or 7.1% on a Same-store Basis, for the Full …
Lands’ End Announces Fourth Quarter and Full Year Fiscal 2024 Results
GlobeNewswire
·
March 20, 2025
Fourth quarter Gross margin increased approximately 760 basis points compared to fiscal 2023 All fourth quarter profitability measures improved when compared to fiscal 2023 Reduced inventory for the eighth consecutive quarter DODGEVILLE, Wis., March 20, …
Commercial Roofing Membrane Market is Projected to Reach US$ 238.2 Million at a CAGR of 3.4% by 2035 | Fact.MR
GlobeNewswire
·
March 20, 2025
Rockville, MD , March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the Commercial Roofing Membrane Market was valued at USD 165.2 million in 2024 and is expected to grow at a CAGR of 3.4% …
SoundThinking Announces TechnoLogic Contract Renewal with New York City Police Department
GlobeNewswire
·
March 20, 2025
Summary: SoundThinking, Inc. today announced a renewal of its partnership with the New York City Police Department for TechnoLogic, its subsidiary providing enterprise resource and investigative case management software and services. FREMONT, Calif., March …
Oncology Small Molecule Drugs Market is Expected to Expand at 5.9% CAGR, Reaching USD 167,635 Million by 2035 | Fact.MR Report
GlobeNewswire
·
March 20, 2025
Rockville, MD , March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global oncology small molecule drugs market is estimated to reach a valuation of USD 94,494 million in 2025 and is …
ORIGENCE LENDING SERVICES SERVES 360,000 MEMBERS AND GROWS TO 167 CREDIT UNIONS IN 2024
GlobeNewswire
·
March 20, 2025
Irvine, California, March 20, 2025 (GLOBE NEWSWIRE) -- Origence Lending Services, a division of Origence, served 360,000 credit union members and grew to 167 credit unions funding $5 billion in 2024. The division also marked a significant milestone in …
FactSet Reports Results for Second Quarter 2025
GlobeNewswire
·
March 20, 2025
Q2 GAAP revenues of $570.7 million, up 4.5% from Q2 2024. Organic Q2 ASV of $2,276.2 million, up 4.1% year over year. Q2 GAAP operating margin of 32.5%, down approximately 80 bps year over year, and adjusted operating margin of 37.3%, down 100 bps year …
Titan Hits Upper Range of Production Guidance and Beats Cost Guidance
GlobeNewswire
·
March 20, 2025
VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) (“Titan” or the "Company") is pleased to announce the results for the year ended December 31, 2024. The Company has achieved the top end of its …
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
GlobeNewswire
·
March 20, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that Mr Paul Rutherford Carter and Mr Graeme Allan Jack, who have both …
[Latest] Global Medical Radioisotopes Market Size/Share Worth USD 1382 Million by 2034 at a 6.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
GlobeNewswire
·
March 20, 2025
Austin, TX, USA, March 20, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Medical Radioisotopes Market Size, Trends and Insights By Type (Tc-99m, Cobalt-60, Iodine Radioisotopes), By Application (Nuclear Therapy …
Laut einer Analyse von SmartRecruiters dauert es in deutschen Unternehmen 55 Tage, um eine offene Stelle zu besetzen
GlobeNewswire
·
March 20, 2025
BERLIN, March 20, 2025 (GLOBE NEWSWIRE) -- Eine Analyse von über 5,1 Millionen Online-Stellenbewerbungen in Deutschland zeigt, dass die durchschnittliche Zeit bis zur Besetzung einer Stelle 55 Tage beträgt und auf jede Stelle 48 Bewerber kommen. Die Studie …
German Businesses Spend 55 Days Filling Each Vacancy According to Analysis by SmartRecruiters
GlobeNewswire
·
March 20, 2025
BERLIN, March 20, 2025 (GLOBE NEWSWIRE) -- Analysis of over 5.1 million online job applications in Germany reveals that the median time to fill a vacancy is 55 days, and each vacancy attracts 48 applicants. The research by SmartRecruiters, the recruiting …
New Zscaler AI Security Report Reveals an Over 3,000% Surge in Enterprise Use of AI/ML Tools
GlobeNewswire
·
March 20, 2025
ChatGPT is the most popular AI/ML application, accounting for nearly half of all AI/ML transactions (45.2%) and is also the most-blocked AI application, followed by Grammarly, and Microsoft Copilot as the second and third most-blocked applications, …
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
GlobeNewswire
·
March 20, 2025
Multi-center clinical trial includes sites located in the US, UK and EU Second Phase II clinical trial studying leniolisib for additional primary immunodeficiencies (PIDs) CVID patients demonstrate clinical phenotypes similar to APDS, with global …
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
GlobeNewswire
·
March 20, 2025
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient market Acquisition advances Paratek’s vision to become a multi-product company focused on …
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
GlobeNewswire
·
March 20, 2025
— SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a promising chemo-free oral treatment strategy to address mechanisms of resistance in the advanced setting — — Long …